Accendra Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,762	2,680	2,553	9,955	9,785
Revenue Growth (YoY)	3.06%	5.00%	-74.36%	1.74%	15.39%
Cost of Revenue	1,473	1,400	1,336	8,037	8,272
Gross Profit	1,289	1,280	1,217	1,919	1,513
Selling, General & Admin	1,069	1,084	1,004	1,557	1,079
Amortization of Goodwill & Intangibles	73.83	39.85	57.8	78.97	39.77
Other Operating Expenses	-	-	-	-6.15	-8.49
Operating Expenses	1,143	1,124	1,062	1,630	1,111
Operating Income	146.21	156.47	155.31	288.89	402.6
Interest Expense	-113.88	-107.57	-116.77	-128.89	-48.09
Currency Exchange Gain (Loss)	-	-	-	-0.9	-2.3
Other Non Operating Income (Expenses)	-13.83	-1.77	-2.46	-1.03	-0.92
EBT Excluding Unusual Items	18.49	47.13	36.08	158.06	351.3
Merger & Restructuring Charges	-120.45	-68.81	-24.34	-54.9	-34.11
Impairment of Goodwill	-	-307.11	-	-	-
Asset Writedown	-	-	-	-92.28	-
Other Unusual Items	-	-1.1	3.52	-	-40.43
Pretax Income	-101.95	-329.89	15.27	10.89	276.75
Income Tax Expense	0.73	20.85	6.36	-11.5	55.17
Earnings From Continuing Operations	-102.68	-350.74	8.91	22.39	221.59
Earnings From Discontinued Operations	-997.96	-11.95	-50.21	-	-
Net Income	-1,101	-362.69	-41.3	22.39	221.59
Net Income to Common	-1,101	-362.69	-41.3	22.39	221.59
Net Income Growth	-	-	-	-89.90%	641.82%
Shares Outstanding (Basic)	77	77	76	74	73
Shares Outstanding (Diluted)	77	77	77	76	75
Shares Change (YoY)	0.20%	-0.81%	1.51%	0.97%	18.85%
EPS (Basic)	-14.31	-4.73	-0.54	0.30	3.05
EPS (Diluted)	-14.32	-4.73	-0.54	0.29	2.94
EPS Growth	-	-	-	-90.14%	523.69%
Free Cash Flow	-292.75	-8.79	568.34	166.92	83.19
Free Cash Flow Per Share	-3.81	-0.12	7.35	2.19	1.10
Dividend Per Share	-	-	-	-	0.010
Gross Margin	46.68%	47.77%	47.68%	19.27%	15.46%
Operating Margin	5.29%	5.84%	6.08%	2.90%	4.11%
Profit Margin	-39.85%	-13.53%	-1.62%	0.22%	2.27%
Free Cash Flow Margin	-10.60%	-0.33%	22.26%	1.68%	0.85%
EBITDA	360.74	337.75	365.68	503.55	482.92
EBITDA Margin	13.06%	12.60%	14.33%	5.06%	4.93%
D&A For EBITDA	214.52	181.28	210.37	214.67	80.32
EBIT	146.21	156.47	155.31	288.89	402.6
EBIT Margin	5.29%	5.84%	6.08%	2.90%	4.11%
Effective Tax Rate	-	-	41.66%	-	19.93%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.